Forskolin as a multi-target modulator of the oncogenic PI3K/Akt signaling pathway: An in silico integrative GO/KEGG enrichment analysis and network pharmacology
This study uses in silico methods to analyze Forskolin's anticancer mechanisms, revealing its targeting of the PI3K/Akt pathway and related oncogenic networks.
bioRxiv · May 11, 2025 · PreprintBioinformatics